文献速递肝病消化道肿瘤与早癌

雄激素受体在肝细胞癌VETC依赖性和侵袭依赖性转移中的双重相反作用

Dual and opposing roles of the androgen receptor in VETC-dependent and invasion-dependent metastasis of hepatocellular carcinoma.
PubMed 文献 · J Hepatol · 2021-05-15

本研究利用小鼠异种移植模型、临床样本和细胞模型,揭示雄激素受体(AR)在肝细胞癌(HCC)转移中的双重相反作用。AR通过抑制Angpt2转录抑制VETC形成和肝内转移,同时通过上调Rac1促进迁移/侵袭和肺转移。

要点

  • AR表达在VETC模式、门静脉癌栓、内皮包绕微栓子或高复发率的HCC中显著降低。
  • AR通过结合Angpt2启动子降低其转录,抑制VETC形成和肝内转移。
  • AR上调Rac1表达促进迁移/侵袭,介导VETC+和VETC- HCC的肺转移。

核心结论

  • AR在VETC依赖性和侵袭依赖性转移中发挥双重相反作用,提示AR功能复杂且个体化治疗重要。

研究设计与样本

  • 使用小鼠异种移植模型、临床样本和细胞模型进行研究。

主要发现

  • AR表达在具有VETC模式、门静脉癌栓、内皮包绕微栓子或高复发率的HCC中显著降低。
  • 在VETC+肝癌细胞中过表达AR抑制VETC形成和肝内转移,但促进小鼠异种移植物的肺转移。
  • AR通过结合Angpt2启动子降低其转录;恢复Angpt2表达可减弱AR对VETC形成和肝内转移的抑制作用。
  • AR上调Rac1表达,促进板状伪足形成和细胞迁移/侵袭;Rac1抑制剂消除AR介导的迁移/侵袭和肺转移促进作用,但不影响AR介导的肝内转移抑制。
  • AR抑制剂降低Rac1表达并减弱VETC-异种移植物的肝内和肺转移,恢复Rac1表达可消除该效应。

临床怎么用

  • AR在HCC转移中的作用具有背景依赖性,需根据VETC状态个体化考虑AR靶向治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Contradictory roles of the androgen receptor (AR) in hepatocellular carcinoma (HCC) metastasis have been reported. We have shown that VETC (vessels encapsulating tumor clusters) mediates invasion-independent metastasis, whereas VETC- HCCs metastasize in an invasion-dependent manner. Herein, we aimed to reveal the roles of AR in HCC metastasis. METHODS: Mouse xenograft models, clinical samples, and cell models were used. RESULTS: AR expression was significantly lower in HCCs with a VETC pattern, portal vein tumor thrombus, endothelium-coated microemboli or high recurrence rates. Overexpressing AR in VETC+ hepatoma cells suppressed VETC formation and intrahepatic metastasis but promoted pulmonary metastasis of mouse xenografts. AR decreased the transcription of Angiopoietin-2 (Angpt2), a factor essential for VETC formation, by binding to the Angpt2 promoter. The roles of AR in inhibiting VETC formation and intrahepatic metastasis were attenuated by restoring Angpt2 expression, suggesting that AR may repress VETC-dependent intrahepatic metastasis by inhibiting Angpt2 expression and VETC formation. On the other hand, AR upregulated Rac1 expression, promoted lamellipodia formation and increased cell migration/invasion. A Rac1 inhibitor abrogated the AR-mediated promotion of migration/invasion and pulmonary metastasis of VETC+ hepatoma cells, but did not affect the AR-mediated inhibition of intrahepatic metastasis. Furthermore, an AR inhibitor decreased Rac1 expression and attenuated both intrahepatic and pulmonary metastasis of VETC- xenografts, an effect which was abrogated by restoring Rac1 expression. These data indicate that AR may facilitate the lung metastasis of VETC+ HCCs and both the liver/lung metastases of VETC- HCCs by upregulating Rac1 expression and then promoting migration/invasion. CONCLUSION: AR plays dual and opposing roles in VETC-dependent and invasion-dependent metastasis, which highlights the complex functions of AR and the importance of individualized cancer therapy. LAY SUMMARY: In this study, we uncovered the dual and opposing roles of the androgen receptor in VETC (vessels encapsulating tumor clusters)-dependent and invasion-dependent metastasis of hepatocellular carcinoma (HCC). We elucidated the underlying mechanisms of these processes, which provided novel insights into the complex regulatory network of the androgen receptor in HCC metastasis and may have important implications for precision medicine.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Zhou HC, Liu CX, Pan WD, et al. Dual and opposing roles of the androgen receptor in VETC-dependent and invasion-dependent metastasis of hepatocellular carcinoma. J Hepatol. 2021. PMID: 34004215. doi:10.1016/j.jhep.2021.04.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。